USA Transplant Market Size, Share, Opportunities, And Trends By Type (Tissue Transplant, Organ Transplant (Living Donors, Deceased Donors)), By Procedure (Autotransplantation, Allotransplantation, Xenotransplantation), And By Product (Immunosuppresive Drugs, Preservation Solutions, Organ Transport Systems) – Forecast From 2023 To 2028

The USA transplant market was valued at US$53.794 billion in 2021 and is projected to expand at a CAGR of 4.73% over the forecast period to reach US$74.364 billion by 2028.

Transplants are also known as grafts or organ transplants where a section of a tissue or a complete organ from its original site is transferred to the area of interest in an individual (same or separate). Thus, the transplanted organ or graft continues to receive nourishment from the new and healthy environment. The prevalence of chronic diseases is one of the major factors driving the growth of the USA transplant market in the forecast period. Furthermore, growing health awareness along with government initiatives regarding organ donation is driving the market growth. However, the shortage of organ donors and incidences of transplant rejection may impede the growth of the USA transplant market during the forecast period. Additionally, technological advancements will drive market growth in the forecast period and the upcoming years.

This research study examines the USA transplant market based on various segments: mode of deployment, type, procedure, and product. First, a brief overview of the market details key driving factors and challenges. Next, Porter's five forces model analyzes the USA transplant industry comprehensively. This is followed by industry value chain analysis which determines the companies which are part of the different processes and contributing to various sectors.

The study also presents in-depth information concerning the development, trends, and industry policies and regulations affecting the USA transplant market. Moreover, the research study analyzes the overall regulatory framework of the USA transplant sector, offering stakeholders a better understanding of the key factors influencing the overall market environment.

USA transplant market – Forecasts from 2023 to 2028 is a comprehensive and latest report. It provides vital market information to executives and interested stakeholders to enable them to get vital market information. The report also analyzes the competitive landscape and details strategies of key market players and also plots them on our vendor matrix in four quadrants: leader, follower, challenger, and niche.

The scope and coverage of the USA transplant market report are as below:

• USA transplant market data tables and charts
• Market outlook with sections on drivers, restraints, Porter’s, and industry value chain analysis
• Market assessment by type into tissue transplant, organ transplant, living donors, and deceased donors.
• Detailed market trends, analysis, and graphical representation of the procedure in autotransplantation, allotransplantation, and xenotransplantation.
• In-depth analysis of the motion control market by product into immunosuppressive drugs, preservation solutions, and organ transport systems.

USA Transplant Market Scope:

Different segments covered under the USA transplant market report are as below:

• By Type
  • Tissue Transplant
  • Organ Transplant
    • Living Donors
    • Deceased Donors
• By Procedure
  • Autotransplantation
  • Allotransplantation
  • Xenotransplantation
• By Product
  • Immunosuppressive drugs
  • Preservation Solutions
  • Organ Transport Systems

1.  INTRODUCTION

1.1. Market Overview

1.2. Market Definition

1.3. Scope of the Study

1.4. Market Segmentation

1.5. Currency

1.6. Assumptions

1.7. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY  

2.1. Research Data

2.2. Assumptions

3. EXECUTIVE SUMMARY

3.1. Research Highlights

4. MARKET DYNAMICS

4.1. Market Drivers

4.2. Market Restraints

4.3. Porter’s Five Force Analysis

4.3.1. Bargaining Power of Suppliers

4.3.2. Bargaining Power of Buyers

4.3.3. Threat of New Entrants

4.3.4. Threat of Substitutes

4.3.5. Competitive Rivalry in the Industry

4.4. Industry Value Chain Analysis

5. USA TRANSPLANT MARKET, BY TYPE

5.1. Introduction

5.2. Tissue Transplant

5.3. Organ Transplant

5.3.1. Living Donors

5.3.2. Deceased Donors

6. USA TRANSPLANT MARKET, BY PROCEDURE 

6.1. Introduction

6.2. Autotransplantation

6.3. Allotransplantation

6.4. Xenotransplantation

7. USA TRANSPLANT MARKET, BY PRODUCT

7.1. Introduction

7.2. Immunosuppressive drugs

7.3. Preservation Solutions

7.4. Organ Transport Systems

8. COMPETITIVE ENVIRONMENT AND ANALYSIS

8.1. Major Players and Strategy Analysis

8.2. Emerging Players and Market Lucrativeness

8.3. Mergers, Acquisitions, Agreements, and Collaborations

8.4. Vendor Competitiveness Matrix

9. COMPANY PROFILES

9.1. TransMedics, Inc.

9.2. Veloxis Pharmaceuticals, Inc.

9.3. Bridge to Life Ltd.

9.4. Paragonix Technologies Inc.

9.5. Global Transplant Solutions

9.6. AbbVie, Inc.

9.7. Arthrex, Inc.

9.8. Medtronic

9.9. Novartis AG

9.10. Stryker

TransMedics, Inc.

Veloxis Pharmaceuticals, Inc.

Bridge to Life Ltd.

Paragonix Technologies Inc.

Global Transplant Solutions

AbbVie, Inc.

Arthrex, Inc.

Medtronic

Novartis AG

Stryker